Suppr超能文献

PIK3CA相关过度生长谱系患者对西罗莫司的快速反应

Rapid Response to Sirolimus in Patients with PIK3CA-Related Overgrowth Spectrum.

作者信息

Nye Jessica R, Green Jackson C, Talanker Michael, Barrera Jose, Richardson Kate, Menon Neethu M, Hebert Adelaide A, Greives Matthew R, Atkinson Autumn A

机构信息

McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, Texas.

Department of Pediatrics, University of Texas Health Science Center at Houston, Houston, Texas.

出版信息

Eplasty. 2024 Dec 13;24:e66. eCollection 2024.

Abstract

-related overgrowth spectrum (PROS) is an umbrella term used to unify a heterogenous group of vascular overgrowth disorders by a shared genetic cause. Given that patients with PROS have a known, or likely, gene mutation in the PI3K/AKT/mTOR cascade, we hypothesize they experience a rapid response to inhibitors of this pathway, including sirolimus. In the following case series, we describe 3 patients with PROS and their response to sirolimus therapy. Despite their unique clinical presentations, insight into the genetic origin of their vascular overgrowth allowed for their successful treatment with the same medication.

摘要

相关过度生长谱系(PROS)是一个统称,用于通过共同的遗传原因将一组异质性血管过度生长疾病统一起来。鉴于PROS患者在PI3K/AKT/mTOR级联反应中有已知的或可能的基因突变,我们推测他们对该途径的抑制剂,包括西罗莫司,会有快速反应。在以下病例系列中,我们描述了3例PROS患者及其对西罗莫司治疗的反应。尽管他们有独特的临床表现,但对其血管过度生长的遗传起源的深入了解使他们能够用同一种药物成功治疗。

相似文献

4
-Related Overgrowth Spectrum From Diagnosis to Targeted Therapy: A Case of CLOVES Syndrome Treated With Alpelisib.
Front Pediatr. 2021 Sep 9;9:732836. doi: 10.3389/fped.2021.732836. eCollection 2021.
5
CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS).
Clin Genet. 2017 Jan;91(1):14-21. doi: 10.1111/cge.12832. Epub 2016 Aug 3.
6
[PIK3CA-related overgrowth syndrome (PROS)].
Nephrol Ther. 2017 Apr;13 Suppl 1:S155-S156. doi: 10.1016/j.nephro.2017.02.004.
7
PIK3CA vascular overgrowth syndromes: an update.
Curr Opin Pediatr. 2020 Aug;32(4):539-546. doi: 10.1097/MOP.0000000000000923.
8
PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.
Am J Med Genet A. 2015 Feb;167A(2):287-95. doi: 10.1002/ajmg.a.36836. Epub 2014 Dec 31.
9
Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.
Am J Med Genet C Semin Med Genet. 2019 Dec;181(4):571-581. doi: 10.1002/ajmg.c.31735. Epub 2019 Sep 6.
10
Clinical Response to PI3K-α Inhibition in a Cohort of Children and Adults With -Related Overgrowth Spectrum Disorders.
J Vasc Anom (Phila). 2022 Mar;3(1). doi: 10.1097/jova.0000000000000038. Epub 2022 Mar 2.

本文引用的文献

1
Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS).
Genet Med. 2023 Dec;25(12):100969. doi: 10.1016/j.gim.2023.100969. Epub 2023 Aug 24.
2
3
New and Emerging Targeted Therapies for Vascular Malformations.
Am J Clin Dermatol. 2020 Oct;21(5):657-668. doi: 10.1007/s40257-020-00528-w.
4
Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.
J Vasc Surg. 2020 Jan;71(1):318-327. doi: 10.1016/j.jvs.2019.06.217. Epub 2019 Oct 30.
5
Effect of sirolimus on coagulopathy of slow-flow vascular malformations.
Pediatr Blood Cancer. 2019 Oct;66(10):e27896. doi: 10.1002/pbc.27896. Epub 2019 Jun 28.
7
Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies.
Eur J Pharm Sci. 2017 Nov 15;109S:S124-S131. doi: 10.1016/j.ejps.2017.05.037. Epub 2017 May 17.
8
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.
Pediatrics. 2016 Feb;137(2):e20153257. doi: 10.1542/peds.2015-3257. Epub 2016 Jan 18.
10
Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).
Exp Dermatol. 2016 Jan;25(1):17-9. doi: 10.1111/exd.12826. Epub 2015 Oct 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验